Feinerman Vision Center

Clinical Research Study Center

Clinical Research Study Center:

As a FDA clinical eye research center, Feinerman Vision Center, is always seeking new technologies and innovative eye care solutions to better our patients’ experience. In the medical field, emerging technologies give us and qualified patients an opportunity to participate in upcoming, advanced clinical research studies as a safe and effective way to improve eye care.

Periodically, we will conduct clinical research studies that comprise of new procedures, treatments, IOLs & other lens types, and eye medication.

As a qualified patient, you can choose to participate in any of these clinical research studies. Depending on the specific study, compensation is sometimes available and can vary. Please ask our staff.

Check any of these following clinical research studies to determine if you qualify first and read more about the benefits of each research study.


Patient Recruitment for Clinical Research Studies:

BAUSCH + LOMB CLINICAL RESEARCH STUDY

Have you been told you have a cataract and astigmatism?

You may qualify to take part in a clinical research study of an investigational intraocular lens that is designed to treat patients with a cataract who also have astigmatism. We are participating in this new study conducted by Bausch + Lomb here in our Newport Beach office.

If you take part in the study you will be asked to return to our office for examinations to evaluate your vision. These visits are at no cost to you.

As a participant you will receive:

  • All study-related exams at no cost
  • Intraocular lens at no cost
  • Some routinely-prescribed eye drops at no cost
  • Compensation for time and travel

Closed to Enrollment

Feinerman Vision Center is currently recruiting volunteers to participate in a clinical research study for individuals over 40 years of age who are having cataract surgery. A clinical trial is being conducted to determine the effectiveness, safety, and tolerability of two different dosages of an investigational medication compared with placebo (an inactive substance). The study medication is injected in the eye at the end of cataract surgery to determine if it can reduce inflammation (a signal of the body to start the healing process characterized by redness, pain, swelling) associated with ocular surgery. To determine eligibility, interested individuals will be examined by Dr. Gregg Feinerman, M.D. as part of a screening visit prior to surgery. After the cataract surgery, there will be at least six follow-up visits that will take place over ninety days. Qualified participants will receive study medication at no cost and compensation for study visits.

For further information about this study, please contact Sheila at 949-631-4780 or .


Cataract Medication Study

Closed to enrollment.


Crystalens for Astigmatism FDA Study

Closed to enrollment.


We would be pleased to provide more information and answer your questions. Please call our office at (949) 631-4780 and ask to speak with Sheila Nardelli.

Community Relations
Community Relations
At Feinerman Vision Center,
we believe that getting
involved with our communities
is essential in building good
will & encouraging growth in society.
Community Relations

Watch More Videos

To find out more about the possibilities of vision correction and LASIK surgery, contact the Newport Beach, Orange County office of Dr. Feinerman today! If you are seeking LASIK in Los Angeles call us today to get the answers you have been seeking.

Listen to Patient Testimonials

Watch more videos of the exciting procedures that Dr. Gregg Feinerman performs at his Newport Beach, California vision correction center. Dr. Feinerman offers the latest technology in vision correction to help patients in Orange County and Southern California see better!

Custom Your Vision Plan

Use our Vision Correction Module to help you determine the best procedure for your unique eyes. Learn about the different types of laser vision correction and how you can customize your surgical plan with Dr. Gregg Feinerman.

Ask Us A Question